A L Pozniak

Summary

Affiliation: Chelsea and Westminster Hospital
Country: UK

Publications

  1. doi request reprint Initiation of antiretroviral therapy
    Anton Pozniak
    Chelsea and Westminster NHS Healthcare Trust, London SW10 9NH, UK
    Curr Opin HIV AIDS 1:398-408. 2006
  2. doi request reprint Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week r
    Anton Pozniak
    HIV Unit, St Stephens Centre, Chelsea and Westminster Hospital, London, UK Electronic address
    Lancet Infect Dis 14:590-9. 2014
  3. doi request reprint HIV-associated neurocognitive disease: case studies and suggestions for diagnosis and management in different patient subgroups
    Anton Pozniak
    Chelsea and Westminster Hospital, London, UK
    Antivir Ther 19:1-13. 2014
  4. pmc Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI
    Carlo Torti
    University of Brescia, Italy
    BMC Infect Dis 11:23. 2011
  5. pmc Elevated ethyl methanesulfonate (EMS) in nelfinavir mesylate (Viracept, Roche): overview
    Anton Pozniak
    Department of HIV and Genitourinary Medicine, Chelsea and Westminster Hospital, London, UK
    AIDS Res Ther 6:18. 2009
  6. doi request reprint Investigational agents for salvage
    Anton L Pozniak
    HIV Services, St Stephen s Centre, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK
    Curr Opin HIV AIDS 4:524-30. 2009
  7. doi request reprint Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial
    Anton L Pozniak
    Chelsea and Westminster NHS Foundation Trust and PKR SSR, London, UK
    AIDS 24:55-65. 2010
  8. ncbi request reprint BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005
    A L Pozniak
    Chelsea and Westminster NHS Healthcare Trust, London, UK
    HIV Med 6:62-83. 2005
  9. doi request reprint Effect of baseline viral susceptibility on response to darunavir/ritonavir versus control protease inhibitors in treatment-experienced HIV type 1-infected patients: POWER 1 and 2
    Anton Pozniak
    Chelsea and Westminster Hospital, London, UK
    AIDS Res Hum Retroviruses 24:1275-80. 2008
  10. doi request reprint Tenofovir: what have over 1 million years of patient experience taught us?
    A Pozniak
    Chelsea and Westminster Hospital, Department of HIV GU Medicine, London, UK
    Int J Clin Pract 62:1285-93. 2008

Detail Information

Publications14

  1. doi request reprint Initiation of antiretroviral therapy
    Anton Pozniak
    Chelsea and Westminster NHS Healthcare Trust, London SW10 9NH, UK
    Curr Opin HIV AIDS 1:398-408. 2006
    ....
  2. doi request reprint Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week r
    Anton Pozniak
    HIV Unit, St Stephens Centre, Chelsea and Westminster Hospital, London, UK Electronic address
    Lancet Infect Dis 14:590-9. 2014
    ..We assessed the non-inferiority of such a switch compared with continuation of an NNRTI-containing regimen...
  3. doi request reprint HIV-associated neurocognitive disease: case studies and suggestions for diagnosis and management in different patient subgroups
    Anton Pozniak
    Chelsea and Westminster Hospital, London, UK
    Antivir Ther 19:1-13. 2014
    ..In this review, we discuss a series of case studies that address some of the challenges presented by the diagnosis and management of HIV-associated neurocognitive impairment in different patient types. ..
  4. pmc Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI
    Carlo Torti
    University of Brescia, Italy
    BMC Infect Dis 11:23. 2011
    ..Data regarding CD4+ recovery after switching from protease inhibitor (PI)-based regimens to regimens not containing PI are scarce...
  5. pmc Elevated ethyl methanesulfonate (EMS) in nelfinavir mesylate (Viracept, Roche): overview
    Anton Pozniak
    Department of HIV and Genitourinary Medicine, Chelsea and Westminster Hospital, London, UK
    AIDS Res Ther 6:18. 2009
    ..These findings are potentially relevant to >40 marketed drugs that are mesylate salts...
  6. doi request reprint Investigational agents for salvage
    Anton L Pozniak
    HIV Services, St Stephen s Centre, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK
    Curr Opin HIV AIDS 4:524-30. 2009
    ..This review will examine some of the compounds that may have a role to play in highly experienced patients in the future...
  7. doi request reprint Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial
    Anton L Pozniak
    Chelsea and Westminster NHS Foundation Trust and PKR SSR, London, UK
    AIDS 24:55-65. 2010
    ..The week 96 analysis of TMC278-C204, a large dose-ranging study of TMC278 in treatment-naive HIV-1-infected patients, is presented...
  8. ncbi request reprint BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005
    A L Pozniak
    Chelsea and Westminster NHS Healthcare Trust, London, UK
    HIV Med 6:62-83. 2005
  9. doi request reprint Effect of baseline viral susceptibility on response to darunavir/ritonavir versus control protease inhibitors in treatment-experienced HIV type 1-infected patients: POWER 1 and 2
    Anton Pozniak
    Chelsea and Westminster Hospital, London, UK
    AIDS Res Hum Retroviruses 24:1275-80. 2008
    ..Darunavir/r 600/100 mg twice daily showed efficacy benefits over CPI use regardless of viral susceptibility at baseline, FC to darunavir or boosting type in a population of treatment-experienced HIV-infected patients...
  10. doi request reprint Tenofovir: what have over 1 million years of patient experience taught us?
    A Pozniak
    Chelsea and Westminster Hospital, Department of HIV GU Medicine, London, UK
    Int J Clin Pract 62:1285-93. 2008
    ..This article reviews the development of tenofovir, including pivotal studies that have influenced HIV clinical practice...
  11. ncbi request reprint British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy
    A Pozniak
    Chelsea and Westminster Hospital, London, UK
    HIV Med 4:1-41. 2003
  12. ncbi request reprint The prevalence of reduced zidovudine susceptibility in zidovudine-naive, antiretroviral-experienced HIV-1-infected patients
    Y Gilleece
    Chelsea and Westminster Hospital, London, UK
    HIV Med 4:305-10. 2003
    ..We assessed phenotypic and genotypic resistance in ZDV-naive patients with virological failure on stavudine (d4T)-containing regimens, with particular reference to potential cross-resistance between d4T and ZDV...
  13. pmc Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapy
    A Pires
    Department of Immunology, Imperial College London, Chelsea and Westminster Hospital, London, UK
    J Immune Based Ther Vaccines 3:7. 2005
    ..Here, we evaluated rises in absolute CD4 T-cells, and specific CD4 T-cell responses in 4 HIV-1+ individuals presenting with mycobacterial associated IRIS who received in conjunction with ART, IL-2 plus GM-CSF immunotherapy...
  14. ncbi request reprint The radiology of IRIS (immune reconstitution inflammatory syndrome) in patients with mycobacterial tuberculosis and HIV co-infection: Appearances in 11 patients
    G Rajeswaran
    Department of Radiology, Chelsea and Westminster Hospital, London, UK
    Clin Radiol 61:833-43. 2006
    ..To determine the radiological manifestations of IRIS (immune reconstitution inflammatory syndrome) in patients with HIV and mycobacterium tuberculosis co-infection, in the context of their demographic and clinical data...